RESEARCH LETTER
 
TOPICS
REFERENCES (17)
1.
Argiro A, Ho C, Day SM, et al. Sex-related differences in genetic cardiomyopathies. J Am Heart Assoc 2022; 11: e024947.
 
2.
Packer M, Coats AJ, Fowler MB, et al.; Carvedilol Prospective Randomized Cumulative Survival Study G. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-8.
 
3.
Zannad F, McMurray JJ, Krum H, et al.; Group E-HS. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011; 364: 11-21.
 
4.
McMurray JJV, Solomon SD, Inzucchi SE, et al.; Committees D-HT, Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019; 381: 1995-2008.
 
5.
Packer M, Anker SD, Butler J, et al.; Investigators EM-RT. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 2020; 383: 1413-24.
 
6.
Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 2017; 390: 2627-42.
 
7.
Wojciechowska C, Jachec W, Romuk E, Nowalany-Kozielska E, Tomasik A, Sieminska L. The effect of BMI, serum leptin, and adiponectin levels on prognosis in patients with non-ischaemic dilated cardiomyopathy. Endokrynol Pol 2017; 68: 26-34.
 
8.
Ye LF, Li XL, Wang SM, Wang YF, Zheng YR, Wang LH. Body mass index: an effective predictor of ejection fraction improvement in heart failure. Front Cardiovasc Med 2021; 8: 586240.
 
9.
Weith M, Beyer A. The next step in Mendelian randomization. Elife 2023; 12: e86416.
 
10.
Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods 2019; 10: 486-96.
 
11.
Long Y, Tang L, Zhou Y, Zhao S, Zhu H. Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study. BMC Med 2023; 21: 66.
 
12.
Xu YS, Liao RY, Huang D, Wang D, Zhang L, Li YZ. Evidence from Mendelian randomization: increased risk of miscarriage in patients with asthma. Eur Rev Med Pharmacol Sci 2023; 27: 11587-96.
 
13.
Bray GA. Beyond BMI. Nutrients 2023; 15: 2254.
 
14.
Clark DO, Mungai SM. Distribution and association of chronic disease and mobility difficulty across four body mass index categories of African-American women. Am J Epidemiol 1997; 145: 865-75.
 
15.
Robertson J, Lindgren M, Schaufelberger M, et al. Body mass index in young women and risk of cardiomyopathy: a long-term follow-up study in Sweden. Circulation 2020; 141: 520-9.
 
16.
Wang X, Liu W, Li H, Ding J, Feng Y, Chen Z. Exploring the role of obesity in dilated cardiomyopathy based on bio-informatics analysis. J Cardiovasc Dev Dis 2022; 9: 462.
 
17.
Rayner JJ, Peterzan MA, Clarke WT, Rodgers CT, Neubauer S, Rider OJ. Obesity modifies the energetic phenotype of dilated cardiomyopathy. Eur Heart J 2021; 43: 868-77.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top